Announcement • Jun 05
Shanghai Kinlita Chemical Co., Ltd., Annual General Meeting, Jun 26, 2026 Shanghai Kinlita Chemical Co., Ltd., Annual General Meeting, Jun 26, 2026, at 14:30 China Standard Time. Reported Earnings • Apr 29
First quarter 2026 earnings released: EPS: CN¥0.03 (vs CN¥0.012 in 1Q 2025) First quarter 2026 results: EPS: CN¥0.03 (up from CN¥0.012 in 1Q 2025). Revenue: CN¥210.2m (up 27% from 1Q 2025). Net income: CN¥14.4m (up 155% from 1Q 2025). Profit margin: 6.8% (up from 3.4% in 1Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. New Risk • Apr 28
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.1% Last year net profit margin: 4.2% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Profit margins are more than 30% lower than last year (2.1% net profit margin). Announcement • Mar 31
Shanghai Kinlita Chemical Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026 Shanghai Kinlita Chemical Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Announcement • Dec 31
Shanghai Kinlita Chemical Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 Shanghai Kinlita Chemical Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 Valuation Update With 7 Day Price Move • Dec 18
Investor sentiment deteriorates as stock falls 24% After last week's 24% share price decline to CN¥4.10, the stock trades at a trailing P/E ratio of 70.2x. Average trailing P/E is 41x in the Chemicals industry in China. Total loss to shareholders of 22% over the past three years. Reported Earnings • Oct 30
Third quarter 2025 earnings released: EPS: CN¥0.019 (vs CN¥0.016 in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.019 (up from CN¥0.016 in 3Q 2024). Revenue: CN¥198.7m (up 14% from 3Q 2024). Net income: CN¥8.89m (up 15% from 3Q 2024). Profit margin: 4.5% (up from 4.4% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Board Change • Oct 01
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Independent Director Hainan Guo was the last director to join the board, commencing their role in 2025. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Announcement • Sep 30
Shanghai Kinlita Chemical Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025 Shanghai Kinlita Chemical Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 Announcement • Sep 16
Shanghai Kinlita Chemical Co., Ltd. Announces Board Appointments Shanghai Kinlita Chemical Co., Ltd. at its 3rd Extraordinary General Meeting of 2025 on 12 September 2025, approved the Election of Ma Anle as a non-independent director and Guo Hainan as an independent director. Valuation Update With 7 Day Price Move • Aug 22
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥5.15, the stock trades at a trailing P/E ratio of 72.2x. Average trailing P/E is 44x in the Chemicals industry in China. Total loss to shareholders of 25% over the past three years. Announcement • Aug 16
Shanghai Kinlita Chemical Co., Ltd. Announces Dismissals of Directors At the 3rd Extraordinary General Meeting of 2025 Shanghai Kinlita Chemical Co., Ltd. will hold the 3rd Extraordinary General Meeting of 2025 on September 12, 2025. The meeting agenda includes the dismissal of Luo Dian as a non-independent director, Yu Xugang as an independent director, and Tang Guangze as an independent director. Valuation Update With 7 Day Price Move • Aug 07
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥4.28, the stock trades at a trailing P/E ratio of 60x. Average trailing P/E is 43x in the Chemicals industry in China. Total loss to shareholders of 43% over the past three years. New Risk • Jul 12
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 28% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 7.9% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Reported Earnings • Jul 03
First quarter 2025 earnings released: EPS: CN¥0.012 (vs CN¥0.006 in 1Q 2024) First quarter 2025 results: EPS: CN¥0.012 (up from CN¥0.006 in 1Q 2024). Revenue: CN¥165.5m (up 4.5% from 1Q 2024). Net income: CN¥5.63m (up 114% from 1Q 2024). Profit margin: 3.4% (up from 1.7% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 113% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Board Change • Jul 03
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. No highly experienced directors. Executive President & Non-Independent Director Dian Luo was the last director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. New Risk • Apr 24
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 9.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 16% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change). Valuation Update With 7 Day Price Move • Apr 24
Investor sentiment deteriorates as stock falls 32% After last week's 32% share price decline to CN¥4.56, the stock trades at a trailing P/E ratio of 70.1x. Average trailing P/E is 36x in the Chemicals industry in China. Total loss to shareholders of 22% over the past three years. Buy Or Sell Opportunity • Apr 16
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 6.4% to CN¥6.71. The fair value is estimated to be CN¥8.39, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Apr 14
Full year 2024 earnings released: EPS: CN¥0.065 (vs CN¥0.03 in FY 2023) Full year 2024 results: EPS: CN¥0.065 (up from CN¥0.03 in FY 2023). Revenue: CN¥731.5m (flat on FY 2023). Net income: CN¥30.9m (up 116% from FY 2023). Profit margin: 4.2% (up from 2.0% in FY 2023). Over the last 3 years on average, earnings per share has increased by 100% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Announcement • Mar 31
Shanghai Kinlita Chemical Co., Ltd. to Report Q1, 2025 Results on Apr 25, 2025 Shanghai Kinlita Chemical Co., Ltd. announced that they will report Q1, 2025 results on Apr 25, 2025 Announcement • Dec 31
Shanghai Kinlita Chemical Co., Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025 Shanghai Kinlita Chemical Co., Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025 New Risk • Nov 07
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 31% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 23% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Buy Or Sell Opportunity • Oct 30
Now 21% undervalued Over the last 90 days, the stock has risen 53% to CN¥8.10. The fair value is estimated to be CN¥10.20, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.4% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Oct 29
Third quarter 2024 earnings released: EPS: CN¥0.016 (vs CN¥0.014 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.016 (up from CN¥0.014 in 3Q 2023). Revenue: CN¥174.6m (down 4.2% from 3Q 2023). Net income: CN¥7.74m (up 9.0% from 3Q 2023). Profit margin: 4.4% (up from 3.9% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 79% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings. Announcement • Sep 30
Shanghai Kinlita Chemical Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 Shanghai Kinlita Chemical Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 New Risk • Sep 18
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.2% average weekly change). Large one-off items impacting financial results. New Risk • Sep 14
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 36% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 30% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Reported Earnings • Aug 30
Second quarter 2024 earnings released: EPS: CN¥0.022 (vs CN¥0.005 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.022 (up from CN¥0.005 in 2Q 2023). Revenue: CN¥188.6m (down 2.0% from 2Q 2023). Net income: CN¥10.4m (up 310% from 2Q 2023). Profit margin: 5.5% (up from 1.3% in 2Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings. Announcement • Jun 29
Shanghai Kinlita Chemical Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Shanghai Kinlita Chemical Co., Ltd. announced that they will report first half, 2024 results on Aug 30, 2024 New Risk • May 27
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 32% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 36% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Reported Earnings • Apr 27
First quarter 2024 earnings released: EPS: CN¥0.006 (vs CN¥0.007 loss in 1Q 2023) First quarter 2024 results: EPS: CN¥0.006 (up from CN¥0.007 loss in 1Q 2023). Revenue: CN¥158.3m (flat on 1Q 2023). Net income: CN¥2.63m (up CN¥6.09m from 1Q 2023). Profit margin: 1.7% (up from net loss in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has fallen by 32% per year, which means it is performing significantly worse than earnings. Announcement • Mar 30
Shanghai Kinlita Chemical Co., Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Shanghai Kinlita Chemical Co., Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024 Announcement • Dec 29
Shanghai Kinlita Chemical Co., Ltd. to Report Fiscal Year 2023 Results on Apr 27, 2024 Shanghai Kinlita Chemical Co., Ltd. announced that they will report fiscal year 2023 results on Apr 27, 2024 New Risk • Dec 07
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Chinese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Earnings have declined by 47% per year over the past 5 years. Reported Earnings • Oct 26
Third quarter 2023 earnings released: EPS: CN¥0.014 (vs CN¥0.058 loss in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.014 (up from CN¥0.058 loss in 3Q 2022). Revenue: CN¥182.3m (down 3.0% from 3Q 2022). Net income: CN¥7.10m (up CN¥35.6m from 3Q 2022). Profit margin: 3.9% (up from net loss in 3Q 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 47 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 30
Second quarter 2023 earnings released: EPS: CN¥0.005 (vs CN¥0.061 loss in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.005 (up from CN¥0.061 loss in 2Q 2022). Revenue: CN¥192.4m (up 35% from 2Q 2022). Net income: CN¥2.53m (up CN¥32.4m from 2Q 2022). Profit margin: 1.3% (up from net loss in 2Q 2022). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance. Announcement • Jun 13
Shanghai Kinlita Chemical Co., Ltd., Annual General Meeting, Jun 30, 2023 Shanghai Kinlita Chemical Co., Ltd., Annual General Meeting, Jun 30, 2023, at 15:00 China Standard Time. Agenda: To consider the 2022 work report of the board of directors; to consider the 2022 work report of the supervisory committee; to consider the 2022 annual accounts; to consider the 2022 profit distribution plan; to consider the 2022 annual report and its summary; to consider the 2023 remuneration (allowance) for directors and senior management; to consider the 2023 remuneration plan for supervisors; to consider the 2023 application for comprehensive credit line to banks; to consider the purchase of wealth management products with idle proprietary funds; to consider the amendments to the connected transactions system; and to consider the amendments to the external investment management system. Reported Earnings • Apr 13
Full year 2022 earnings released: CN¥0.23 loss per share (vs CN¥0.23 loss in FY 2021) Full year 2022 results: CN¥0.23 loss per share (in line with FY 2021). Revenue: CN¥646.9m (down 25% from FY 2021). Net loss: CN¥113.1m (loss widened 2.2% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 94 percentage points per year, which is a significant difference in performance. Board Change • Nov 16
High number of new and inexperienced directors There are 11 new directors who have joined the board in the last 3 years. The company's board is composed of: 11 new directors. 1 experienced director. No highly experienced directors. Independent Director Yibing Wu is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 27
Third quarter 2022 earnings released: CN¥0.058 loss per share (vs CN¥0.085 loss in 3Q 2021) Third quarter 2022 results: CN¥0.058 loss per share (improved from CN¥0.085 loss in 3Q 2021). Revenue: CN¥187.9m (up 2.3% from 3Q 2021). Net loss: CN¥28.5m (loss narrowed 31% from 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 95 percentage points per year, which is a significant difference in performance. Reported Earnings • Aug 31
Second quarter 2022 earnings released: CN¥0.061 loss per share (vs CN¥0.081 loss in 2Q 2021) Second quarter 2022 results: CN¥0.061 loss per share (up from CN¥0.081 loss in 2Q 2021). Revenue: CN¥142.3m (down 41% from 2Q 2021). Net loss: CN¥29.9m (loss narrowed 25% from 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 90 percentage points per year, which is a significant difference in performance. Buying Opportunity • Jul 12
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 13%. The fair value is estimated to be CN¥8.13, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.8% over the last 3 years. Meanwhile, the company became loss making. Announcement • Jun 11
Shanghai Kinlita Chemical Co., Ltd., Annual General Meeting, Jun 30, 2022 Shanghai Kinlita Chemical Co., Ltd., Annual General Meeting, Jun 30, 2022, at 15:00 China Standard Time. Agenda: To discuss 2021 work report of the board of directors; to review 2021 work report of the supervisory committee; to approve 2021 annual accounts; to discuss 2021 profit distribution plan; to approve 2021 annual report and its summary; to reappoint 2022 audit firm; to review 2022 remuneration (allowance) for directors and senior management; to discuss 2022 remuneration plan for supervisors; and to discuss other related matters. Buying Opportunity • May 24
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 45%. The fair value is estimated to be CN¥8.14, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.8% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • May 02
First quarter 2022 earnings: EPS in line with expectations, revenues disappoint First quarter 2022 results: CN¥0.054 loss per share (down from CN¥0.045 profit in 1Q 2021). Revenue: CN¥170.0m (down 29% from 1Q 2021). Net loss: CN¥26.2m (down 219% from profit in 1Q 2021). Revenue missed analyst estimates by 7.2%. Earnings per share (EPS) were also behind analyst expectations. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Board Change • Apr 27
High number of new and inexperienced directors There are 12 new directors who have joined the board in the last 3 years. The company's board is composed of: 12 new directors. No experienced directors. No highly experienced directors. Non-Employee Supervisor Wei Wang is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Apr 17
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Full year 2021 results: CN¥0.22 loss per share (down from CN¥0.19 profit in FY 2020). Revenue: CN¥858.0m (down 3.1% from FY 2020). Net loss: CN¥108.4m (down 219% from profit in FY 2020). Revenue missed analyst estimates by 7.2%. Earnings per share (EPS) were also behind analyst expectations. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Announcement • Apr 07
Shanghai Kinlita Chemical Co., Ltd. Announces Board Changes Shanghai Kinlita Chemical Co., Ltd. at its Extraordinary General Meeting held on April 01, 2022, approved dismissal of Liu Jinmei as a non-independent director and dismissal of Wang Lan as an independent director. The meeting also approved Election of Luo Dian and Wu Chunchao as non-independent directors; Ma Weihua and Yu Xugang as independent directors; and Shen Xudong and Zhu Shunjie as supervisors. Reported Earnings • Oct 27
Third quarter 2021 earnings released: CN¥0.085 loss per share (vs CN¥0.11 profit in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: CN¥183.7m (down 29% from 3Q 2020). Net loss: CN¥41.4m (down 182% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has increased by 45% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Aug 09
Second quarter 2021 earnings released: CN¥0.081 loss per share (vs CN¥0.033 profit in 2Q 2020) The company reported a soft second quarter result with weaker earnings and weaker control over costs, although revenues improved. Second quarter 2021 results: Revenue: CN¥239.9m (up 8.0% from 2Q 2020). Net loss: CN¥39.8m (down 366% from profit in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 40% per year, which means it is significantly lagging earnings growth. Reported Earnings • Apr 30
First quarter 2021 earnings released: EPS CN¥0.045 (vs CN¥0.001 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥239.6m (up 109% from 1Q 2020). Net income: CN¥22.0m (up CN¥21.6m from 1Q 2020). Profit margin: 9.2% (up from 0.3% in 1Q 2020). The increase in margin was driven by higher revenue. Reported Earnings • Mar 19
Full year 2020 earnings released: EPS CN¥0.19 (vs CN¥0.064 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: CN¥885.0m (up 8.8% from FY 2019). Net income: CN¥91.4m (up 204% from FY 2019). Profit margin: 10% (up from 3.7% in FY 2019). The increase in margin was driven by higher revenue. Is New 90 Day High Low • Feb 22
New 90-day high: CN¥24.35 The company is up 2.0% from its price of CN¥23.98 on 24 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 18% over the same period. Announcement • Feb 18
Shanghai Kinlita Chemical Co., Ltd. to Report Fiscal Year 2020 Results on Mar 16, 2021 Shanghai Kinlita Chemical Co., Ltd. announced that they will report fiscal year 2020 results on Mar 16, 2021 Is New 90 Day High Low • Dec 13
New 90-day low: CN¥12.28 The company is down 5.0% from its price of CN¥12.90 on 14 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 8.0% over the same period. Is New 90 Day High Low • Nov 20
New 90-day high: CN¥24.57 The company is up 113% from its price of CN¥11.52 on 21 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. Is New 90 Day High Low • Oct 27
New 90-day high: CN¥19.10 The company is up 117% from its price of CN¥8.81 on 29 July 2020. The Chinese market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. Reported Earnings • Oct 16
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥70.0m, up 141% from the prior year. Total revenue was CN¥845.4m over the last 12 months, up 3.4% from the prior year. Announcement • Oct 16
Shanghai Kinlita Chemical Co., Ltd. to Report Q3, 2020 Results on Oct 16, 2020 Shanghai Kinlita Chemical Co., Ltd. announced that they will report Q3, 2020 results on Oct 16, 2020 Is New 90 Day High Low • Oct 09
New 90-day high: CN¥16.30 The company is up 119% from its price of CN¥7.45 on 10 July 2020. The Chinese market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. Is New 90 Day High Low • Sep 22
New 90-day high: CN¥13.97 The company is up 118% from its price of CN¥6.41 on 24 June 2020. The Chinese market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 23% over the same period. Announcement • Jul 23
Shanghai Kinlita Chemical Co., Ltd. to Report First Half, 2020 Results on Aug 18, 2020 Shanghai Kinlita Chemical Co., Ltd. announced that they will report first half, 2020 results on Aug 18, 2020 
